These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25727557)

  • 21. Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer.
    Dawood S; Gonzalez-Angulo AM
    Cancer Biomark; 2012-2013; 12(6):241-50. PubMed ID: 23735944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties.
    Van de Wiel M; Dockx Y; Van den Wyngaert T; Stroobants S; Tjalma WAA; Huizing MT
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():144-156. PubMed ID: 28039758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Mauri D; Pavlidis N; Ioannidis JP
    J Natl Cancer Inst; 2005 Feb; 97(3):188-94. PubMed ID: 15687361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future role of neoadjuvant therapy for breast cancer.
    Untch M; Konecny GE; Paepke S; von Minckwitz G
    Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant endocrine therapy for breast cancer: medical perspectives.
    Ellis MJ
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4388s-4391s; discussion 4411s-4412s. PubMed ID: 11916229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical usefulness and relevance of intermediate endpoints for cytotoxic neoadjuvant therapy.
    Fontanella C; Loibl S; von Minckwitz G
    Breast; 2015 Nov; 24 Suppl 2():S84-7. PubMed ID: 26279131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between tumour size and response to neoadjuvant chemotherapy among breast cancer patients in a tertiary center in Nigeria.
    Samuel O; Olayide A; Ganiyu R; Olufemi H; Halimat A
    Malawi Med J; 2018 Mar; 30(1):13-16. PubMed ID: 29868153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant therapy as a platform for drug development and approval in breast cancer.
    Bardia A; Baselga J
    Clin Cancer Res; 2013 Dec; 19(23):6360-70. PubMed ID: 24298066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.
    Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H
    Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.
    Collie-Duguid ES; Sweeney K; Stewart KN; Miller ID; Smyth E; Heys SD
    Breast Cancer Res Treat; 2012 Apr; 132(3):807-18. PubMed ID: 21695460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination.
    Tiezzi DG; Andrade JM; Ribeiro-Silva A; Zola FE; Marana HR; Tiezzi MG
    BMC Cancer; 2007 Feb; 7():36. PubMed ID: 17324279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant therapy for breast cancer.
    Zardavas D; Piccart M
    Annu Rev Med; 2015; 66():31-48. PubMed ID: 25386936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
    Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
    Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there still a role for neoadjuvant therapy in breast cancer?
    Shannon C; Smith I
    Crit Rev Oncol Hematol; 2003 Jan; 45(1):77-90. PubMed ID: 12482573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary systemic therapy of breast cancer.
    Sachelarie I; Grossbard ML; Chadha M; Feldman S; Ghesani M; Blum RH
    Oncologist; 2006 Jun; 11(6):574-89. PubMed ID: 16794237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on neoadjuvant/preoperative therapy of breast cancer: experiences from the German Breast Group.
    von Minckwitz G; Untch M; Loibl S
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):66-73. PubMed ID: 23262654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the relevance between molecular subtypes and efficacy of neoadjuvant chemotherapy in breast cancer as well as its prognostic factors.
    Li F; Ma L; Geng C; Liu C; Deng H; Yue M; Ding Y; Wang X; Liu Y
    Pathol Res Pract; 2018 Aug; 214(8):1166-1172. PubMed ID: 29945816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.
    De La Cruz LM; Harhay MO; Zhang P; Ugras S
    Ann Surg Oncol; 2018 Nov; 25(12):3535-3540. PubMed ID: 29981025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials.
    Reinisch M; Huober J; von Minckwitz G; Blohmer JU; Denkert C; Hanusch C; Jackisch C; Kümmel S; Schneeweiss A; Rhiem K; Lederer B; Untch M; Nekljudova V V; Loibl S
    Breast; 2017 Apr; 32():73-78. PubMed ID: 28063331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.